跳至主要内容
临床试验/NCT03321604
NCT03321604终止不适用

Kidney Information Network for Disease Research and Education (KINDRED)

Massachusetts General Hospital1 个研究点 分布在 1 个国家目标入组 338 人开始时间: 2018年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
338
试验地点
1
主要终点
Genetically determined Fabry disease prevalence amongst a heterogenous patient population with end-stage renal disease on dialysis in the US not previously known to have Fabry disease.

研究概览

简要总结

In this study, Investigators will conduct a prospective cohort study of dialysis patients by collecting research-quality information on patient characteristics, comorbid diseases and laboratory markers used in routine practice, as well as novel biochemical markers and genetic data. Investigators will utilize data from the cohort to test the independent relationship between biochemical and genetic markers and Fabry disease and other rare diseases.

详细描述

KINDRED is a prospective observational cohort study that will enroll up to 5,000 dialysis patients throughout the United States with and without known diagnosis of Fabry disease but at risk for Fabry disease (e.g., unknown cause of renal disease, young male, initiating dialysis without a kidney biopsy, etc).This tissue repository will allow for genetic screening of a geographically diverse population, assist in identification of rare diseases in ESRD, and collect research-quality information on risk factors and outcomes from an ethnically heterogeneous population of dialysis patients. In this study, Investigators will use a novel method of performing research in this population by leveraging the internet to enhance and accelerate recruitment of potential subjects to participate in a genetic screening/tissue repository protocol.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults between 18 and 65 with ESRD undergoing dialysis.

排除标准

  • Kidney biopsy unlikely to be Fabry disease; those with a diagnosis that is clinically or biochemically proven not to be Fabry disease.

结局指标

主要结局

Genetically determined Fabry disease prevalence amongst a heterogenous patient population with end-stage renal disease on dialysis in the US not previously known to have Fabry disease.

时间窗: 5 years

次要结局

  • Differences in patient characteristics of dialysis patients diagnosed with Fabry disease vs. dialysis patients who do not have Fabry disease.(5 years)
  • Differences in patient characteristics of individuals diagnosed with Fabry disease initiating dialysis after 2013 vs. patients with Fabry disease who started dialysis before 2003.(5 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ravi Thadhani

Principal Investigator

Massachusetts General Hospital

研究点 (1)

Loading locations...

相似试验

Kidney Information Network for Disease Research and... | 临床试验